Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Immunotherapy for early triple negative breast cancer: research agenda for the next decade

(2022) Paolo Tarantino et al.   npj Breast Cancer

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

(2021) András Lánczky et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein

(2021) Tyler W. Jenkins et al.   Scientific Reports

The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer

(2021) Satyendra Chandra Tripathi et al.   Cells

Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma

(2020) Shelly Kalaora et al.   Nature Communications

The pros and cons of interferons for oncolytic virotherapy

(2020) Karen Geoffroy et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Expression of the immunoproteasome subunit β5i in non-small cell lung carcinomas

(2020) Takayuki Kiuchi et al.   JOURNAL OF CLINICAL PATHOLOGY

Comparative Assessment of the WNT/β-Catenin Pathway, CacyBP/SIP, and the Immunoproteasome Subunit LMP7 in Various Histological Types of Renal Cell Carcinoma

(2020) Żaneta Piotrowska et al.   Frontiers in Oncology

Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer

(2019) Nikolas Tim Martin et al.   Scientific Reports

The neoepitope landscape of breast cancer: implications for immunotherapy

(2019) Pooja Narang et al.   BMC CANCER

Mutation-Derived Neoantigens for Cancer Immunotherapy

(2019) John C. Castle et al.   Frontiers in Immunology

The Immune Microenvironment of Breast Cancer Progression

(2019) Tower et al.   Cancers

PSMB8 regulates glioma cell migration, proliferation, and apoptosis through modulating ERK1/2 and PI3K/AKT signaling pathways

(2018) Bing-ya Yang et al.   BIOMEDICINE & PHARMACOTHERAPY

Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy

(2018) Marie-Claude Bourgeois-Daigneault et al.   Science Translational Medicine

Oncogenic addiction to high 26S proteasome level

(2018) Peter Tsvetkov et al.   Cell Death & Disease

Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers

(2018) Miseon Lee et al.   Cancer Research and Treatment

Proteasome inhibitors in cancer therapy

(2017) Elisabet E. Manasanch et al.   Nature Reviews Clinical Oncology

Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice

(2017) Julia Koerner et al.   Oncotarget

Immunoproteasome functions explained by divergence in cleavage specificity and regulation

(2017) Michael B Winter et al.   eLife

Doxorubicin-Induced Systemic Inflammation Is Driven by Upregulation of Toll-Like Receptor TLR4 and Endotoxin Leakage

(2016) Lintao Wang et al.   CANCER RESEARCH

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome

(2016) Satyendra C. Tripathi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity

(2016) Marie-Claude Bourgeois-Daigneault et al.   Molecular Therapy-Oncolytics

Expression of immunoproteasome genes is regulated by cell-intrinsic and –extrinsic factors in human cancers

(2016) Alexandre Rouette et al.   Scientific Reports

New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells

(2015) Hiroaki Kimura et al.   Journal of Immunology Research

Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma

(2014) Lenka Kubiczkova et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Proteasome Functioning in Breast Cancer: Connection with Clinical-Pathological Factors

(2014) Elena E. Shashova et al.   PLoS One

Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

(2014) Dinesh Vyas et al.   OncoTargets and Therapy

A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells

(2013) Fabio Petrocca et al.   CANCER CELL

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

(2013) T. M. Herndon et al.   CLINICAL CANCER RESEARCH

Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

(2013) A. Prat et al.   ONCOLOGIST

Comparative Quantitative Analysis of Cluster of Differentiation 45 Antigen Expression on Lymphocyte Subsets

(2011) Mijeong Im et al.   Korean Journal of Laboratory Medicine

Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)

(2009) A Arlt et al.   ONCOGENE

How basal are triple-negative breast cancers?

(2008) François Bertucci et al.   INTERNATIONAL JOURNAL OF CANCER

Basal-Like Breast Cancer: A Critical Review

(2008) Emad A. Rakha et al.   JOURNAL OF CLINICAL ONCOLOGY